文献
J-GLOBAL ID:202102233365694910
整理番号:21A2277673
プロリルエンドペプチダーゼ阻害剤Y-29794はIRS1-AKT-mTORC1経路を遮断し,トリプルネガティブ乳癌の生存とin vivo腫瘍増殖を阻害する【JST・京大機械翻訳】
Prolyl endopeptidase inhibitor Y-29794 blocks the IRS1-AKT-mTORC1 pathway and inhibits survival and in vivo tumor growth of triple-negative breast cancer
著者 (6件):
Perez Ricardo E
(Department of Cell and Molecular Medicine, Rush University Medical Center, Chicago, IL, USA)
,
Calhoun Sarah
(Department of Cell and Molecular Medicine, Rush University Medical Center, Chicago, IL, USA)
,
Shim Daeun
(Department of Cell and Molecular Medicine, Rush University Medical Center, Chicago, IL, USA)
,
Levenson Victor V.
(Department of Cell and Molecular Medicine, Rush University Medical Center, Chicago, IL, USA)
,
Duan Lei
(Department of Cell and Molecular Medicine, Rush University Medical Center, Chicago, IL, USA)
,
Maki Carl G.
(Department of Cell and Molecular Medicine, Rush University Medical Center, Chicago, IL, USA)
資料名:
Cancer Biology & Therapy
(Cancer Biology & Therapy)
巻:
21
号:
11
ページ:
1033-1040
発行年:
2020年
JST資料番号:
W5803A
ISSN:
1538-4047
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
イギリス (GBR)
言語:
英語 (EN)